En Es
Categories

Industry News

Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders

By Labmedica International staff writers
13 Jan 2022

Illustration

The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.


These are the latest findings of Transparency Market Research (Albany NY, USA), a market intelligence provider.


Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.


There has been rise in the incidence and prevalence of blood disorders such as hemophilia over the last few years. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools, which in turn, is likely to propel the growth of the global coagulometers market. Moreover, the rising consumption of anti-coagulant drugs such as aspirin and heparin that necessitates the use of coagulometers to monitor the treatment progress in those patients is also fueling market growth. However, the high cost of these devices is diverting potential users towards manual coagulation testing, which is expected to restrain the growth of the global coagulometers market.


Based on technology, the global coagulometers market is dominated by the photo-optical detection and electrochemical detection segments which hold the highest market share as most automated coagulometers work on the principle of photo-optical or electrochemical detection. Based on channel type, the multichannel coagulometers segment holds the largest share in the global coagulometers market as multichannel coagulometers are widely used in diagnostic laboratories and hospitals. Based on end-user, the hospitals & diagnostic laboratories segment is expected to account for a major share of the global coagulometers market.


Geographically, North America is expected to hold a major share of the global coagulometers market, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global coagulometers market due to the high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market for coagulometers in the region.


Related Links:
Transparency Market Research 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

18 Jan 2022
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.
Read More
17 Jan 2022
Mobile C-Arms Market to Surpass USD 1.6 Billion in 2027 Due to Growing Preference for Minimally Invasive Surgeries
The global mobile C-arms market is expected to grow at a CAGR of 5.2% from USD 1.07 billion in 2019 to USD 1.61 billion in 2027, driven primarily by an increase in the global geriatric population, rising burden of chronic and acute diseases across the world, increasing volumes of orthopedic, cardiac, neurological, and oncological surgical procedures, and growing preference for minimally invasive surgeries.
Read More
14 Jan 2022
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East when it returns to the Dubai World Trade Center from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. (Seoul, Korea) taking center stage.
Read More
11 Jan 2022
Medlab Middle East to Return as Standalone Event in 2023
Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.
Read More
11 Jan 2022
J&J Medical Devices Companies Partners with Microsoft to Further Enable its Digital Surgery Solutions
The Johnson & Johnson Medical Devices Companies (JJMDC; New Brunswick, NJ, USA) will collaborate with Microsoft (Redmond, Wash., USA; www.microsoft.com) to further enable and expand JJMDC’s secure and compliant digital surgery ecosystem.
Read More
10 Jan 2022
ICU Medical Completes Acquisition of Smiths Medical to Create Leading Infusion Therapy Company
ICU Medical Inc. (San Clemente, CA, USA) has completed its acquisition of Smiths Medical (Minneapolis, MN, USA) from Smiths Group plc that includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical's existing businesses, the combined companies create a leading infusion therapy company.
Read More
05 Jan 2022
Global Portable Ultrasound Scanner Market to Be Driven by Rising Trauma and Accident Cases
The global portable ultrasound scanner market is being driven by an increase in targeted illnesses, rise in trauma & accident cases, surge in demand for less invasive operations, and the emergence of a senior population at a high risk of diseases.
Read More
04 Jan 2022
Global Mammography Workstations Market to Surpass USD 0.19 Billion in 2028 Due to Increasing Prevalence of Breast Cancer
The global mammography workstations market is projected to grow at a CAGR of 6.8% from about USD 0.12 billion in 2020 to more than USD 0.19 billion in 2028, led by increasing prevalence of breast cancer across the world, growing need for early breast cancer diagnosis and treatment, rise in government initiatives to spread breast cancer awareness, and rapid adoption of advanced mammography workstations in hospitals, clinics, and breast care centers.
Read More
30 Dec 2021
Global Ultrasound Device Market to Reach USD 9.5 Billion by 2027 Due to Rising Prevalence of Chronic Disorders
The global ultrasound devices market is projected to grow at a CAGR of 4.73% from USD 7.2 billion in 2021 to USD 9.5 billion by 2027, driven by a rise in the prevalence of chronic disorders such as cancer tumors, gallstones, fatty liver disease, and high spending on the healthcare industry.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions